Skip to main content
Top
Published in: Systematic Reviews 1/2022

Open Access 01-12-2022 | Protocol

The effects of exercise on circulating endocannabinoid levels—a protocol for a systematic review and meta-analysis

Authors: Viviane Bristot, Giorgio Poletto, Débora Maria Russiano Pereira, Melina Hauck, Ione Jayce Ceola Schneider, Aderbal S. Aguiar Jr

Published in: Systematic Reviews | Issue 1/2022

Login to get access

Abstract

Background

Increased circulating endocannabinoids levels are typically associated with aerobic exercise. This phenomenon is associated with a “runner’s high,” a state of euphoria and well-being experienced after a long exercise. We will provide in this review a transparent and standardized methodology following the PRISMA-P and Cochrane Handbook for Systematic Reviews of Interventions for conducting a systematic review and meta-analysis for synthesizing the available evidence about the effects of physical activity on the circulating levels of AEA and 2-AG endocannabinoids in healthy subjects.

Methods

A multi-disciplinary team with basic and clinical expertise in exercise science developed this protocol. PubMed, EMBASE, Web of Science, CINAHL, SPORTDiscus, and Scopus will be the databases. A health sciences librarian was consulted in the development of the research. Search strategies will combine MeSH terms and free text words, including “exercise,” “exercise, physical,” “exercise training,” “physical activity,” “endocannabinoids,” “2-arachidonoyl-glycerol,” “glyceryl 2-arachidonate,” “2-AG,” “anandamide,” “AEA,” “n-arachidonoylethanolamide,” “adult,” “young adult,” and “middle-aged.” We will select experimental or quasi-experimental studies published through December 2021. The selection of studies, data extraction, assessment of the risk of bias, and the quality of evidence will be carried out in a paired and independent manner, and the consistency will be assessed using the statistics of Cohen Kappa. Methodological quality will be assessed using the Revised Cochrane risk of bias tool for randomized trials (RoB 2) and the Risk Of Bias In Nonrandomized Studies of Interventions (ROBINS-I) risk tool. We will use the Grading of Recommendations Assessment, Development, and Evaluation to assess the quality of the evidence, χ2 and I2 tests for heterogeneity, funnel plots, and the Egger test for publication bias. A meta-analysis for each data comparison will be performed whenever possible to determine the effect of physical activity on endocannabinoids’ circulating levels.

Discussion

This systematic review and meta-analysis will provide an overview of the evidence about physical activity over AEA and 2-AG endocannabinoids, including comparability of variables between studies, critical interpretation of results, and use of accurate statistical techniques. The endocannabinoid is molecules by which muscles communicate with other tissues and organs, mediating the beneficial effects of exercise on health and performance, including increased glucose uptake, improved insulin action, and mitochondrial biogenesis. They are essential to exercise. Thus, this study will review the acute effect of physical exercise on circulating levels of endocannabinoids in healthy individuals. The results of this study will potentially be transferred to doctors, health professionals, and legislators to guide their decision making, as well as will improve future research.

Systematic review registration

PROSPERO CRD42020202886.
Appendix
Available only for authorised users
Literature
1.
go back to reference Watkins BA. Endocannabinoids, exercise, pain, and a path to health with aging. Mol Asp Med. 2018;64:68–78.CrossRef Watkins BA. Endocannabinoids, exercise, pain, and a path to health with aging. Mol Asp Med. 2018;64:68–78.CrossRef
2.
go back to reference Hodges EL, Ashpole NM. Aging circadian rhythms and cannabinoids. Neurobiol Aging. 2019;79:110–8.CrossRef Hodges EL, Ashpole NM. Aging circadian rhythms and cannabinoids. Neurobiol Aging. 2019;79:110–8.CrossRef
3.
4.
go back to reference Tóth KF, Ádám D, Bíró T, Oláh A. Cannabinoid signaling in the skin: therapeutic potential of the “C(ut)annabinoid” system. Molecules. 2019;24(5):918.CrossRef Tóth KF, Ádám D, Bíró T, Oláh A. Cannabinoid signaling in the skin: therapeutic potential of the “C(ut)annabinoid” system. Molecules. 2019;24(5):918.CrossRef
5.
go back to reference Forte N, Fernández-Rilo AC, Palomba L, Di Marzo V, Cristino L. Obesity affects the microbiota-gut-brain axis and the regulation thereof by endocannabinoids and related mediators. Int J Mol Sci. 2020;21(5):1554.CrossRef Forte N, Fernández-Rilo AC, Palomba L, Di Marzo V, Cristino L. Obesity affects the microbiota-gut-brain axis and the regulation thereof by endocannabinoids and related mediators. Int J Mol Sci. 2020;21(5):1554.CrossRef
6.
go back to reference Wang HQ, Han J. The endocannabinoid system regulates the moderate exercise-induced enhancement of learning and memory in mice. J Sports Med Phys Fitness. 2020;60(2):320–8.CrossRef Wang HQ, Han J. The endocannabinoid system regulates the moderate exercise-induced enhancement of learning and memory in mice. J Sports Med Phys Fitness. 2020;60(2):320–8.CrossRef
7.
go back to reference Storozhuk MV, Zholos AV. TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling. Curr Neuropharmacol. 2018;16(2):137–50.CrossRef Storozhuk MV, Zholos AV. TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling. Curr Neuropharmacol. 2018;16(2):137–50.CrossRef
8.
go back to reference Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM, Druart C, et al. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol. 2016;12(3):133–43.CrossRef Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM, Druart C, et al. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol. 2016;12(3):133–43.CrossRef
9.
go back to reference Di Liegro CM, Schiera G, Proia P, Di Liegro I. Physical activity and brain health. Genes. 2019;10:9. Di Liegro CM, Schiera G, Proia P, Di Liegro I. Physical activity and brain health. Genes. 2019;10:9.
10.
go back to reference Dietrich A, McDaniel WF. Endocannabinoids and exercise. Br J Sports Med. 2004;38(5):536–41.CrossRef Dietrich A, McDaniel WF. Endocannabinoids and exercise. Br J Sports Med. 2004;38(5):536–41.CrossRef
11.
go back to reference Hillard CJ. Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology. 2018;43(1):155–72.CrossRef Hillard CJ. Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology. 2018;43(1):155–72.CrossRef
12.
go back to reference Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur J Appl Physiol. 2013;113(4):869–75.CrossRef Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. Eur J Appl Physiol. 2013;113(4):869–75.CrossRef
13.
go back to reference Hicks SD, Jacob P, Perez O, Baffuto M, Gagnon Z, Middleton FA. The transcriptional signature of a runner’s high. Med Sci Sports Exerc. 2019;51(5):970–8.CrossRef Hicks SD, Jacob P, Perez O, Baffuto M, Gagnon Z, Middleton FA. The transcriptional signature of a runner’s high. Med Sci Sports Exerc. 2019;51(5):970–8.CrossRef
14.
go back to reference Hughes L, Patterson SD. The effect of blood flow restriction exercise on exercise-induced hypoalgesia and endogenous opioid and endocannabinoid mechanisms of pain modulation. J Appl Physiol (1985). 2020;128(4):914–24.CrossRef Hughes L, Patterson SD. The effect of blood flow restriction exercise on exercise-induced hypoalgesia and endogenous opioid and endocannabinoid mechanisms of pain modulation. J Appl Physiol (1985). 2020;128(4):914–24.CrossRef
15.
go back to reference Stensson N, Grimby-Ekman A. Altered relationship between anandamide and glutamate in circulation after 30 min of arm cycling: a comparison of chronic pain subject with healthy controls. Mol Pain. 2019;15:1744806919898360.CrossRef Stensson N, Grimby-Ekman A. Altered relationship between anandamide and glutamate in circulation after 30 min of arm cycling: a comparison of chronic pain subject with healthy controls. Mol Pain. 2019;15:1744806919898360.CrossRef
16.
go back to reference Bisogno T, Di Marzo V. The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses. Curr Pharm Des. 2008;14(23):2299–3305.CrossRef Bisogno T, Di Marzo V. The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses. Curr Pharm Des. 2008;14(23):2299–3305.CrossRef
17.
go back to reference Charytoniuk T, Zywno H, Konstantynowicz-Nowicka K, Berk K, Bzdega W, Chabowski A. Can physical activity support the endocannabinoid system in the preventive and therapeutic approach to neurological disorders? Int J Mol Sci. 2020;21(12):4221.CrossRef Charytoniuk T, Zywno H, Konstantynowicz-Nowicka K, Berk K, Bzdega W, Chabowski A. Can physical activity support the endocannabinoid system in the preventive and therapeutic approach to neurological disorders? Int J Mol Sci. 2020;21(12):4221.CrossRef
18.
go back to reference Loprinzi PD, Zou LY, Li H. The endocannabinoid system as a potential mechanism through which exercise influences episodic memory function. Brain Sci. 2019;9(5):112.CrossRef Loprinzi PD, Zou LY, Li H. The endocannabinoid system as a potential mechanism through which exercise influences episodic memory function. Brain Sci. 2019;9(5):112.CrossRef
19.
go back to reference Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013;17(4):475–90.CrossRef Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013;17(4):475–90.CrossRef
20.
go back to reference Tantimonaco M, Ceci R, Sabatini S, Catani MV, Rossi A, Gasperi V, et al. Physical activity and the endocannabinoid system: an overview. Cell Mol Life Sci. 2014;71(14):2681–98.CrossRef Tantimonaco M, Ceci R, Sabatini S, Catani MV, Rossi A, Gasperi V, et al. Physical activity and the endocannabinoid system: an overview. Cell Mol Life Sci. 2014;71(14):2681–98.CrossRef
21.
go back to reference Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.CrossRef Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.CrossRef
24.
go back to reference McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV, Thomas J. Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane; 2020. Available from www.training.cochrane.org/handbook. McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV, Thomas J. Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane; 2020. Available from www.​training.​cochrane.​org/​handbook.
25.
go back to reference Regnaux JP, Lefevre-Colau MM, Trinquart L, Nguyen C, Boutron I, Brosseau L, et al. High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis. Cochrane Database Syst Rev. 2015;(10):CD010203. Regnaux JP, Lefevre-Colau MM, Trinquart L, Nguyen C, Boutron I, Brosseau L, et al. High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis. Cochrane Database Syst Rev. 2015;(10):CD010203.
26.
go back to reference Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.CrossRef Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.CrossRef
27.
go back to reference Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.CrossRef Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.CrossRef
28.
go back to reference Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.CrossRef Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.CrossRef
29.
go back to reference Review Manager (RevMan) [Computer program]. Version 5.4, The Cochrane Collaboration, 2020. Review Manager (RevMan) [Computer program]. Version 5.4, The Cochrane Collaboration, 2020.
31.
go back to reference Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.CrossRef Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.CrossRef
32.
go back to reference GRADEpro GDT. GRADEpro Guideline Development Tool [Software]: McMaster University; 2015. (developed by Evidence Prime, Inc.). Available from gradepro.org GRADEpro GDT. GRADEpro Guideline Development Tool [Software]: McMaster University; 2015. (developed by Evidence Prime, Inc.). Available from gradepro.​org
Metadata
Title
The effects of exercise on circulating endocannabinoid levels—a protocol for a systematic review and meta-analysis
Authors
Viviane Bristot
Giorgio Poletto
Débora Maria Russiano Pereira
Melina Hauck
Ione Jayce Ceola Schneider
Aderbal S. Aguiar Jr
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2022
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-022-01980-x

Other articles of this Issue 1/2022

Systematic Reviews 1/2022 Go to the issue